The Pharmacy Times® Diabetes Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of chronic diseases that result in high blood glucose.
September 15th 2025
GLP-1 receptor agonists enhance glycemic control and weight management in youth with type 2 diabetes (T2D) and obesity, while safety concerns persist.
Oral Semaglutide Demonstrates Benefits for Patients With Type 2 Diabetes
September 20th 2018A global phase 3a trial successfully demonstrated greater reductions in HbA1c and body weight with a oral semaglutide drug treatment than with dulaglutide, as well as a a comparable number of adverse events in 458 Japanese adults with type 2 diabetes between these medications.
Read More
ASCEND Trial: Aspirin Prevents Serious Vascular Events in Diabetes
August 27th 2018Serious vascular events in patients with diabetes can be prevented with aspirin use, according to results of the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial, which were presented at the ongoing ESC Congress in Munich, Germany.
Read More
Trial Results Confirm Aspirin Prevents Primary Vascular Events in Patients With Diabetes
August 27th 2018Serious vascular events in patients with diabetes can be prevented with aspirin use, according to results of the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial, which were presented at the ESC Congress in Munich, Germany.
Read More
Repatha Significantly Improved Cholesterol Levels in High-Risk Patients with Type 2 Diabetes
June 26th 2018New data demonstrate that evolocumab (Repatha) significantly reduced low-density lipoprotein cholesterol and non-high density lipoprotein cholesterol in patients with type 2 diabetes plus hypercholesterolemia or mixed dyslipidemia.
Read More
New Data Show Oral Semaglutide Significantly Reduced A1C in Adults with Type 2 Diabetes
June 25th 2018Newly published findings from the PIONEER 1 phase 3a trial show that once-daily once-daily oral semaglutide was associated with significant reductions in blood sugar in adults with type 2 diabetes.
Read More